Halberd Co. (OTCMKTS:HALB) Sees Significant Decline in Short Interest

Halberd Co. (OTCMKTS:HALB) saw a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 700 shares, a decline of 96.9% from the December 31st total of 22,300 shares. Based on an average daily volume of 1,645,800 shares, the days-to-cover ratio is currently 0.0 days.

Halberd Trading Up 12.9 %

Halberd stock traded up $0.00 during trading hours on Thursday, hitting $0.00. The stock had a trading volume of 562,265 shares, compared to its average volume of 557,688. Halberd has a one year low of $0.00 and a one year high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.